SCHEMBL357830

SCHEMBL357830

O=C(O)C1CCC2CCN1C2

nearest known ligand 0.40

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.34
ACE P12821 4/20 0.33
SLC18A3 Q16572 1/20 0.33
AGTR2 P50052 2/20 0.31
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
REN P00797 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11086482 0.86 SLC18A3 (0.38) ACESLC18A3ALDH1A1SMN1; SMN2REN
SCHEMBL901345 0.84 ATM (0.35) ATMACEAGTR2ALDH1A1SMN1; SMN2
SCHEMBL2428126 0.84 ATM (0.35) ATMACEAGTR2ALDH1A1SMN1; SMN2
SCHEMBL30599165 0.84 ATM (0.33) ATMACESLC18A3ALDH1A1SMN1; SMN2
SCHEMBL15265282 0.75 ALDH1A1 (0.42) ACEALDH1A1SMN1; SMN2REN
Bromide SCHEMBL9704530 0.75
SCHEMBL572684 0.75 ACE (0.36) ATMACEALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL5473763 0.73 ACE (0.35) ATMACEALDH1A1SMN1; SMN2
SCHEMBL4024975 0.73
Hydrochloric Acid SCHEMBL14343353 0.73 ACE (0.35) ATMACEALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2568805-A1 A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID Vivoline Medical AB (SE) 2013-03-20 EP disclosed
WO-2012009263-A1 COCAINE ANALOGS AND METHODS OF PREPARATION AND USES THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2012-01-19 WO disclosed
WO-2011142705-A1 A MEDICAL FLUID, A METHOD OF TREATMENT AND USE OF THE FLUID VIVOLINE MEDICAL AB (SE) 2011-11-17 WO disclosed